INBS
Intelligent Bio Solutions Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.23
−3.04%Margins
Gross margin
27.7%
EBITDA margin
-273.6%
EBIT margin
-305.0%
Net margin
-294.9%
FCF margin
-289.5%
-225.6%
Return on equity
-104.1%
Return on assets
-175.4%
Return on invested capital
0.31x
Asset turnover
-$12.1M
Cash from operations
$1.32
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026